Literature DB >> 27001958

Cutting Edge: Foxp1 Controls Naive CD8+ T Cell Quiescence by Simultaneously Repressing Key Pathways in Cellular Metabolism and Cell Cycle Progression.

Hairong Wei1, Jianlin Geng1, Bi Shi1, Zhenghui Liu1, Yin-Hu Wang1, Anna C Stevens1, Stephanie L Sprout1, Min Yao2, Haikun Wang3, Hui Hu4.   

Abstract

Previously we have shown that transcription factor Foxp1 plays an essential role in maintaining naive T cell quiescence; in the absence of Foxp1, mature naive CD8(+) T cells proliferate in direct response to homeostatic cytokine IL-7. In this study, we report that the deletion of Foxp1 in naive CD8(+) T cells leads to enhanced activation of the PI3K/Akt/mammalian target of rapamycin signaling pathway and its downstream cell growth and metabolism targets in response to IL-7. We found that Foxp1 directly regulates PI3K interacting protein 1, a negative regulator of PI3K. Additionally, we found that deletion of Foxp1 in naive CD8(+) T cells results in increased expression levels of E2fs, the critical components for cell cycle progression and proliferation, in a manner that is not associated with increased phosphorylation of retinoblastoma protein. Taken together, our studies suggest that Foxp1 enforces naive CD8(+) T cell quiescence by simultaneously repressing key pathways in both cellular metabolism and cell cycle progression.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27001958      PMCID: PMC4868629          DOI: 10.4049/jimmunol.1501896

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  IL-7 is critical for homeostatic proliferation and survival of naive T cells.

Authors:  J T Tan; E Dudl; E LeRoy; R Murray; J Sprent; K I Weinberg; C D Surh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

Review 2.  E2F target genes: unraveling the biology.

Authors:  Adrian P Bracken; Marco Ciro; Andrea Cocito; Kristian Helin
Journal:  Trends Biochem Sci       Date:  2004-08       Impact factor: 13.807

3.  The E2F transcription factor is a cellular target for the RB protein.

Authors:  S P Chellappan; S Hiebert; M Mudryj; J M Horowitz; J R Nevins
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

Review 4.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

5.  Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.

Authors:  A S Lundberg; R A Weinberg
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

6.  Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites.

Authors:  E S Knudsen; J Y Wang
Journal:  J Biol Chem       Date:  1996-04-05       Impact factor: 5.157

7.  Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.

Authors:  K M Hsiao; S L McMahon; P J Farnham
Journal:  Genes Dev       Date:  1994-07-01       Impact factor: 11.361

8.  E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints.

Authors:  Bing Ren; Hieu Cam; Yasuhiko Takahashi; Thomas Volkert; Jolyon Terragni; Richard A Young; Brian David Dynlacht
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

9.  The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.

Authors:  M Kitagawa; H Higashi; H K Jung; I Suzuki-Takahashi; M Ikeda; K Tamai; J Kato; K Segawa; E Yoshida; S Nishimura; Y Taya
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

10.  Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor.

Authors:  Yann M Kerdiles; Daniel R Beisner; Roberto Tinoco; Anne S Dejean; Diego H Castrillon; Ronald A DePinho; Stephen M Hedrick
Journal:  Nat Immunol       Date:  2009-01-11       Impact factor: 25.606

View more
  19 in total

1.  Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism.

Authors:  Marc O Johnson; Melissa M Wolf; Matthew Z Madden; Gabriela Andrejeva; Ayaka Sugiura; Diana C Contreras; Damian Maseda; Maria V Liberti; Katelyn Paz; Rigel J Kishton; Matthew E Johnson; Aguirre A de Cubas; Pingsheng Wu; Gongbo Li; Yongliang Zhang; Dawn C Newcomb; Andrew D Wells; Nicholas P Restifo; W Kimryn Rathmell; Jason W Locasale; Marco L Davila; Bruce R Blazar; Jeffrey C Rathmell
Journal:  Cell       Date:  2018-11-01       Impact factor: 41.582

Review 2.  Rethinking peripheral T cell tolerance: checkpoints across a T cell's journey.

Authors:  Mohamed A ElTanbouly; Randolph J Noelle
Journal:  Nat Rev Immunol       Date:  2020-10-19       Impact factor: 53.106

3.  Exhaustion-associated regulatory regions in CD8+ tumor-infiltrating T cells.

Authors:  Giuliana P Mognol; Roberto Spreafico; Victor Wong; James P Scott-Browne; Susan Togher; Alexander Hoffmann; Patrick G Hogan; Anjana Rao; Sara Trifari
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-10       Impact factor: 11.205

4.  Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients.

Authors:  Leopoldo N Segal; Jose C Clemente; Yonghua Li; Chunhai Ruan; Jane Cao; Mauricio Danckers; Alison Morris; Sarah Tapyrik; Benjamin G Wu; Philip Diaz; Gregory Calligaro; Rodney Dawson; Richard N van Zyl-Smit; Keertan Dheda; William N Rom; Michael D Weiden
Journal:  Cell Host Microbe       Date:  2017-03-30       Impact factor: 21.023

5.  PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.

Authors:  Cécile Naudin; Aurore Hattabi; Fabio Michelet; Ayda Miri-Nezhad; Aissa Benyoucef; Françoise Pflumio; François Guillonneau; Serge Fichelson; Isabelle Vigon; Isabelle Dusanter-Fourt; Evelyne Lauret
Journal:  Blood       Date:  2017-02-23       Impact factor: 22.113

6.  Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers.

Authors:  Josephine R Giles; Sasikanth Manne; Elizabeth Freilich; Derek A Oldridge; Amy E Baxter; Sangeeth George; Zeyu Chen; Hua Huang; Lakshmi Chilukuri; Mary Carberry; Lydia Giles; Nan-Ping P Weng; Regina M Young; Carl H June; Lynn M Schuchter; Ravi K Amaravadi; Xiaowei Xu; Giorgos C Karakousis; Tara C Mitchell; Alexander C Huang; Junwei Shi; E John Wherry
Journal:  Immunity       Date:  2022-03-08       Impact factor: 43.474

7.  The transcription factor Rfx7 limits metabolism of NK cells and promotes their maintenance and immunity.

Authors:  Wilson Castro; Sonia T Chelbi; Charlène Niogret; Cristina Ramon-Barros; Suzanne P M Welten; Kevin Osterheld; Haiping Wang; Giorgia Rota; Leonor Morgado; Eric Vivier; Miro E Raeber; Onur Boyman; Mauro Delorenzi; David Barras; Ping-Chih Ho; Annette Oxenius; Greta Guarda
Journal:  Nat Immunol       Date:  2018-07-02       Impact factor: 25.606

Review 8.  Forkhead box transcription factors as context-dependent regulators of lymphocyte homeostasis.

Authors:  Dietmar M W Zaiss; Paul J Coffer
Journal:  Nat Rev Immunol       Date:  2018-11       Impact factor: 53.106

Review 9.  Genetic and environmental factors underlying keratinocyte carcinoma risk.

Authors:  Hélène Choquet; Sepideh Ashrafzadeh; Yuhree Kim; Maryam M Asgari; Eric Jorgenson
Journal:  JCI Insight       Date:  2020-05-21

10.  Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy.

Authors:  Mary Jo Turk; Christina V Angeles; Jichang Han; Yanding Zhao; Keisuke Shirai; Aleksey Molodtsov; Fred W Kolling; Jan L Fisher; Peisheng Zhang; Shaofeng Yan; Tyler G Searles; Justin M Bader; Jiang Gui; Chao Cheng; Marc S Ernstoff
Journal:  Nat Cancer       Date:  2021-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.